Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Ophthalmology

Director TERASAKI, Hiroko (Professor)   9W

Efforts in the most advanced treatment demonstrated by excellent treatment results

Our department specializes particularly in retinal and vitreous disease and actively performs advanced, high-quality treatment for diseases such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. We have achieved excellent treatment results including more than 700 retinal and vitreous surgeries in a year.

Medical Care System

Professor (Terasaki, Hiroko); one associate professor; two lecturers; one clinical lecturer; three assistant professors; one designated assistant professor; four clinical assistant professors, and nine part-time doctors.

Target Disease

Retinal and vitreous disease, macular degeneration, retinal degeneration, cataract, uveitis, dry eye, corneal disease, strabismus / amblyopia, pediatric eye disease, eye tumor, and ophthalmoplasty.

Strong Fields

Retinal and vitreous surgery for diseases such as diabetic retinopathy, retinal detachment, macular hole, and premacular membrane. Photodynamic therapy and new drug therapies including molecular targeted drugs such as anti-VEGF agents, and so forth, for age-related macular degeneration and macular edema.

Clinical Results

The annual number of first-visit patients is about 3,500, and the annual total number of revisit patients is about 36,000. The annual total number of surgeries is about 1,000, of which 700 surgeries are for retinal and vitreous diseases. We have achieved excellent treatment results for about 480 patients a year with age-related macular degeneration who are treated with photodynamic therapy and drug infusion.

Specialized Outpatient Clinic

Retinal and vitreous disease, corneal disease, strabismic amblyopia / pediatric eye disease, uveal disease, eye tumor, ophthalmoplasty, and low vision.

Advanced Medicine and Research

We promote elucidation of the pathology of diseases such as age-related macular degeneration, diabetic retinopathy, and retinal pigment degeneration and the development of new therapies. Especially, we are highly reputed worldwide in the fields of diagnosis and assessment of retinal disease using electroretinographic techniques.